Rick Randall’s initial foray into leading a Medtech company represented a bit of a fairy tale. But his next chapter – starting and leading spine company Trans1 – serves as a bit of a Medtech nightmare.

Stanford’s Yock Talks Medtech Costs, Biodesign’s Birthday, and How He Feels about Apple and Google

A weekly conversation with the innovators who will change how health care is delivered.